SCHEMBL6169622

SCHEMBL6169622

COc1ccccc1N1CCN(C(C=O)n2nc(C(F)(F)F)c(Cl)c2C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
CCR1 P32246 4/20 0.41
CYP2C19 P33261 2/20 0.41
KCNH2 Q12809 1/20 0.41
ALOX15 P16050 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP3A5 P20815 1/20 0.41
LMNA P02545 5/20 0.41
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TSHR P16473 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR7 P34969 1/20 0.40
HTR6 P50406 1/20 0.40
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025793 0.90 CCR1 (0.42) CCR1CYP2C19KCNH2
SCHEMBL4018406 0.89 CCR1 (0.42) CCR1CYP2C19KCNH2DRD2
SCHEMBL4019925 0.88 CCR1 (0.40) CCR1CYP2C19KCNH2LMNAHTT
SCHEMBL4018084 0.87 LMNA (0.42) GAACCR1LMNASMN1; SMN2ALDH1A1
SCHEMBL4304679 0.86 CCR1 (0.48) CCR1CYP2C19KCNH2
SCHEMBL4018792 0.85 CCR1 (0.47) CCR1CYP2C19KCNH2
SCHEMBL4016533 0.84 CCR1 (0.39) GAACCR1LMNAHTTSMN1; SMN2
SCHEMBL4331728 0.84 CCR1 (0.47) CCR1CYP2C19KCNH2
SCHEMBL4017802 0.84 CCR1 (0.49) CCR1CYP2C19KCNH2
SCHEMBL4019904 0.84 CCR1 (0.53) CCR1CYP2C19KCNH2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531822-A1 1-ARYL-4-SUBSTITUTED PIPERAZINE DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS Chemocentryx, Inc. (US) 2005-05-25 EP disclosed
WO-2003105853-A1 1-ARYL-4-SUBSTITUTED PIPERAZINES DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS CHEMOCENTRYX, INC. (US) 2003-12-24 WO disclosed